Community Screening Study of Diabetic Retinopathy in Tianjin in 2024
Recruiting
Observational Study
Diabetic Retinopathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 18,000 (estimated)
- Sponsor
- Li Xiaorong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Through this study, the investigators hope to understand the prevalence and influencing factors of diabetic retinopathy in Tianjin, improve the ability of complication detection and intervention in diabetic patients in primary medical and health institutions, and build a diabetes prevention and treatment network. The investigators should adhere to the policy of prevention first, combined with prev…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
\- 1: Clear awareness, barrier-free communication
2: diabetes
Exclusion Criteria:
* 1: Have left the registered home address
2: In the last 6 months, you have not lived in your place of residence
3: Have a serious mental illness
Contacts